Sunday is International Day of Women and Girls in Science. It’s an opportunity to raise the profile of the many exciting opportunities a career in science may bring and celebrate the achievements of women in science. The medical charity LifeArc is an important research partner for Cystic Fibrosis Trust; we chatted to LifeArc colleague Dr Katy Kettleborough about what she loves about her role and her advice to women and girls who are setting out in careers in science.
Do you have cystic fibrosis (CF) and are looking for, or want to stay in, work or education? We can support you to find and stay in education or your chosen career.
We have today received confirmation that agreements between Vertex and NHS Wales and Vertex and NHS Northern Ireland have been finalised. The agreement is comparable to the NHS England one, announced on Thursday 20 June, and will provide access to modulator therapies for all existing and future eligible CF patients in Wales and Northern Ireland.
The National Institute for Health and Care Excellence (NICE) have today (20 June) given approval for the life changing cystic fibrosis (CF) modulator drugs – Kaftrio, Symkevi and Orkambi - to be made available on the NHS in England. This follows many years of campaigning by Cystic Fibrosis Trust and people right across the CF community.
Bowel Research UK have today released a special episode of their podcast, Can I Butt In? for CF Week, discussing the connection between cystic fibrosis and bowel conditions.
For 60 years we've worked together, sharing moments of frustration, despair and hope, overcoming challenges, and celebrating breakthroughs. Always learning and moving forward. This CF Week, we’re reflecting on how far we’ve come and looking to the future. Because we won’t stop until CF does.
Today, we’re going inside the lab to chat to CF researcher Professor Pietro Cicuta, who is based at the University of Cambridge. “I think CF still holds a lot of mysteries,” he tells us.
